Merck, headquartered in darmstadt, Germany, is actually the world's leading biotechnology company, and its medium-term business focuses on medical health and life sciences. It is reported that Merck's acquisition of AmpTec and its PCR technology is mainly due to its rich professional knowledge in the field of lipid manufacturing. The acquisition of AmpTec enabled Merck to independently provide products in the mRNA value chain, which significantly reduced the speed and cost of research and development and accelerated the listing process of Merck.
Why do so many online games sometimes think that buying AmpTec is a waste of time and money? Mainly, the purpose of this acquisition is mainly to develop COVID-19 vaccines, but now COVID-19 vaccines in many countries are basically on the market, or they are all ready to go on the market. When to develop a vaccine at this time, let alone when to go on the market. Even after listing, most humans have been vaccinated. And quite a few countries have chosen some vaccines that have been vaccinated and have no sequelae. Many countries will be conservative about your company's new vaccine. For the cost of your previous acquisition and the cost of developing vaccines, these are not small expenses, and they are not small burdens for most companies. This is why so many netizens are not optimistic about Merck's acquisition of AmpTec in Germany.
Of course, for us ordinary people, immediate interests may be very important, but Merck in Germany doesn't think so. They look to the long term. The main purpose of acquiring AmpTec is to obtain some patents related to the original company, such as AmpTec MRNA. For a company, the company is not very valuable, but the patent of this company is very valuable.
AmpTec is a biotechnology company, and its technology is in demand in other related companies, so it is worthwhile to buy this company in the long run. We hope Merck in Germany can develop better and better.